SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

August 26, 2013 08:30 ET

Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Summit San Francisco', Oct. 16-18, 2013, InterContinental Mark Hopkins Hotel

Participating Investors Will Include: RCT BioVentures, Domain Associates, MVM Life Science Partners, Bay City Capital, Saratoga Ventures, Lightstone Venture Capital, Psilos Group, Abbott Laboratories, Terumo Medical, Coviden, Abingworth, Johnson & Johnson Development Corp., Alloy Ventures and Interwest Partners

SAN FRANCISCO, CA--(Marketwired - Aug 26, 2013) - Elsevier Business Intelligence ("EBI"), the medtech industry's leading provider of strategic partnership and investment conferences, announced today that it will host the 'IN3 Medical Device 360° Summit San Francisco' investor conference on Oct. 16-18, 2013, at the InterContinental Mark Hopkins San Francisco. 

The Investment in Innovation (IN3) Medical Device 360° Summit San Francisco conference will feature presentations by more than 30 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2013 and beyond. Also, large company/VC meet-and-greets will be held to facilitate interaction between these two influential groups and conference participants. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged. 

In addition to all of the customary conference benefits, presenting company CEOs will have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. These interviews will be featured post-conference at www.in3tv.com, to which a link will be provided to participating companies for their unrestricted use. All one-on-one interviews with presenting-company CEOs will be organized by medtech PR/IR expert Ronald Trahan, APR, President of Ronald Trahan Associates, Inc. Videotaping will take place on a scheduled basis only, on one day only of the event: Thursday, Oct. 17, from 1:00-5:30 p.m. PDT. To schedule the free on-camera interviews contact rctrahan@ronaldtrahan.com, or call +1-508-359-4005, x108.

The 'IN3 Medical Device 360° Summit San Francisco' investor conference will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in San Francisco should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com

Event co-sponsors to date include Ronald Trahan Associates Inc., Marketwired, ISIS Services, Knobbe Martens, MedMarc, Nutek Corp., Exponent, CanBiotech Innovations, Worldwide Pharma Connections, Avalere Health, Stanford-Taiwan STPI-Narl, and Life Science Intelligence. Visit www.in3SanFrancisco.com for more information. 

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bedminster, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

Contact Information

  • Contact:
    Ronald Trahan
    APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108